Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.837,83
-0,20%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Deciphera Pharmaceuticals Inc (DCPH) Deciphera Pharmaceuticals Inc (DCPH) Notizie

Deciphera Pharmaceuticals Inc

DCPH
25,59
0,00 (0,00%)
22 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/6/202414:02EDGAR2Form 15-12G - Securities registration termination [Section..
14/6/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
12/6/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202423:18EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/6/202423:02EDGAR2Form POS AM - Post-Effective amendments for registration..
11/6/202423:01EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
11/6/202415:25EDGAR2Form 8-K - Current report
11/6/202415:18EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/6/202415:15EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
03/6/202413:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
03/6/202413:00BWDeciphera Pharmaceuticals Announces Oral Presentation of..
28/5/202412:08EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
22/5/202415:06EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
22/5/202413:01EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
13/5/202412:32EDGAR2Form SC 14D9 - Solicitation, recommendation statements
13/5/202412:31EDGAR2Form SC TO-T - Tender offer statement by Third Party
10/5/202413:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202423:16EDGAR2Form SC TO-C - Written communication relating to an issuer..
29/4/202413:00BWDeciphera Pharmaceuticals to be Acquired by ONO..
09/4/202413:00BWDeciphera Pharmaceuticals to Present at the Stifel 2024..
27/2/202413:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
20/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202413:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/2/202413:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/2/202413:10EDGAR2Form 8-K - Current report
06/2/202413:00BWDeciphera Pharmaceuticals Announces Fourth Quarter and Full..
01/2/202422:50BWDeciphera Pharmaceuticals to Announce Fourth Quarter and..
01/2/202413:00BWDeciphera Pharmaceuticals to Present at the Guggenheim..
18/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:13BWDeciphera Pharmaceuticals Presents Long-Term Follow-Up..
08/1/202413:14EDGAR2Form 8-K - Current report
08/1/202413:00BWDeciphera Pharmaceuticals Announces Planned 2024 Corporate..
05/1/202413:00BWDeciphera Pharmaceuticals Announces Nature Medicine..
02/1/202413:00BWDeciphera Pharmaceuticals to Present at the 42nd Annual J.P...
14/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 25,59

La tua Cronologia

NASDAQ
DCPH
Deciphera Pharmaceuticals
NASDAQ
DHCNL
Diversified Healthcare
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network